Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease

IntroductionThere is few effective biomarkers for diagnosing nonalcoholic fatty liver disease (NAFLD) in clinical practice. This study was aimed to investigate the predictive ability of novel inflammatory biomarkers, including the monocyte to high-density lipoprotein cholesterol ratio (MHR), neutrop...

Full description

Bibliographic Details
Main Authors: Yanhua Zhao, Junxiang Xia, He He, Shanshan Liang, He Zhang, Wei Gan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.981196/full
_version_ 1811186945860042752
author Yanhua Zhao
Junxiang Xia
Junxiang Xia
He He
Shanshan Liang
He Zhang
Wei Gan
author_facet Yanhua Zhao
Junxiang Xia
Junxiang Xia
He He
Shanshan Liang
He Zhang
Wei Gan
author_sort Yanhua Zhao
collection DOAJ
description IntroductionThere is few effective biomarkers for diagnosing nonalcoholic fatty liver disease (NAFLD) in clinical practice. This study was aimed to investigate the predictive ability of novel inflammatory biomarkers, including the monocyte to high-density lipoprotein cholesterol ratio (MHR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR), for NAFLD.MethodsA total of 4465 outpatients diagnosed with NAFLD and 3683 healthy controls were enrolled between May 2016 and November 2021 from the West China Hospital of Sichuan University, and anthropometric and laboratory examination data were collected. The two-sample Mann-Whitney U test and binary logistic regression analysis were used to evaluate the correlations between four inflammatory biomarkers and NAFLD. The areas under the curves (AUCs) of receiver operating characteristic were used to evaluate their predictive ability for NAFLD.ResultsThe MHR, NLR and LMR were higher in patients with NAFLD than in healthy controls (P<0.001), whereas the PLR was remarkably lower (P<0.001). The OR values of the MHR, NLR, PLR, and LMR were 1.599 (1.543-1.658), 1.250 (1.186-1.317), 0.987(0.986-0.988) and 1.111(1.083-1.139), respectively(P<0.001). After adjusting for confounding factors, MHR was still the most relevant risk factor for NAFLD compared with other inflammatory markers (P<0.001). The AUCs of the MHR, NLR, PLR, and LMR were as follows: 0.663 (0.651-0.675), 0.524 (0.512-0.537), 0.329 (0.318-0.341), and 0.543 (0.530-0.555), respectively (P<0.001). Furthermore, the diagnostic model combining the MHR with alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides, fasting blood glucose, creatinine, uric acid, and body mass index had the best AUC of 0.931 (0.925-0.936).ConclusionsMHR was superior to NLR, PLR and LMR as an inflammatory biomarker in the prediction of NAFLD. When combined with relevant laboratory parameters, the MHR may improve the clinical noninvasive diagnosis of NAFLD.
first_indexed 2024-04-11T13:54:50Z
format Article
id doaj.art-4d80533ad1414fa78121550fcd0b450c
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T13:54:50Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-4d80533ad1414fa78121550fcd0b450c2022-12-22T04:20:24ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-11-011310.3389/fendo.2022.981196981196Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver diseaseYanhua Zhao0Junxiang Xia1Junxiang Xia2He He3Shanshan Liang4He Zhang5Wei Gan6Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Laboratory Medicine, Sichuan Province Orthopedic Hospital, Chengdu, ChinaDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, ChinaDepartment of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, ChinaIntroductionThere is few effective biomarkers for diagnosing nonalcoholic fatty liver disease (NAFLD) in clinical practice. This study was aimed to investigate the predictive ability of novel inflammatory biomarkers, including the monocyte to high-density lipoprotein cholesterol ratio (MHR), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR), for NAFLD.MethodsA total of 4465 outpatients diagnosed with NAFLD and 3683 healthy controls were enrolled between May 2016 and November 2021 from the West China Hospital of Sichuan University, and anthropometric and laboratory examination data were collected. The two-sample Mann-Whitney U test and binary logistic regression analysis were used to evaluate the correlations between four inflammatory biomarkers and NAFLD. The areas under the curves (AUCs) of receiver operating characteristic were used to evaluate their predictive ability for NAFLD.ResultsThe MHR, NLR and LMR were higher in patients with NAFLD than in healthy controls (P<0.001), whereas the PLR was remarkably lower (P<0.001). The OR values of the MHR, NLR, PLR, and LMR were 1.599 (1.543-1.658), 1.250 (1.186-1.317), 0.987(0.986-0.988) and 1.111(1.083-1.139), respectively(P<0.001). After adjusting for confounding factors, MHR was still the most relevant risk factor for NAFLD compared with other inflammatory markers (P<0.001). The AUCs of the MHR, NLR, PLR, and LMR were as follows: 0.663 (0.651-0.675), 0.524 (0.512-0.537), 0.329 (0.318-0.341), and 0.543 (0.530-0.555), respectively (P<0.001). Furthermore, the diagnostic model combining the MHR with alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides, fasting blood glucose, creatinine, uric acid, and body mass index had the best AUC of 0.931 (0.925-0.936).ConclusionsMHR was superior to NLR, PLR and LMR as an inflammatory biomarker in the prediction of NAFLD. When combined with relevant laboratory parameters, the MHR may improve the clinical noninvasive diagnosis of NAFLD.https://www.frontiersin.org/articles/10.3389/fendo.2022.981196/fullnonalcoholic fatty liver diseasemonocyte to high-density lipoprotein cholesterol rationeutrophil to lymphocyte ratioplatelet to lymphocyte ratiolymphocyte to monocyte ratio
spellingShingle Yanhua Zhao
Junxiang Xia
Junxiang Xia
He He
Shanshan Liang
He Zhang
Wei Gan
Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
Frontiers in Endocrinology
nonalcoholic fatty liver disease
monocyte to high-density lipoprotein cholesterol ratio
neutrophil to lymphocyte ratio
platelet to lymphocyte ratio
lymphocyte to monocyte ratio
title Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
title_full Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
title_fullStr Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
title_full_unstemmed Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
title_short Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
title_sort diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
topic nonalcoholic fatty liver disease
monocyte to high-density lipoprotein cholesterol ratio
neutrophil to lymphocyte ratio
platelet to lymphocyte ratio
lymphocyte to monocyte ratio
url https://www.frontiersin.org/articles/10.3389/fendo.2022.981196/full
work_keys_str_mv AT yanhuazhao diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease
AT junxiangxia diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease
AT junxiangxia diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease
AT hehe diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease
AT shanshanliang diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease
AT hezhang diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease
AT weigan diagnosticperformanceofnovelinflammatorybiomarkersbasedonratiosoflaboratoryindicatorsfornonalcoholicfattyliverdisease